CRP and non-small cell lung carcinoma: This work is consistent with previous work in patients with inoperable non-small-cell lung cancer (Forrest et al, 2003, 2004, 2005) and improves on the prediction of survival using an elevated C-reactive protein alone (Albuquerque et al, 1995; Zhang and Adachi, 1999).